Nature Communications (May 2024)

Disease related changes in ATAC-seq of iPSC-derived motor neuron lines from ALS patients and controls

  • Stanislav Tsitkov,
  • Kelsey Valentine,
  • Velina Kozareva,
  • Aneesh Donde,
  • Aaron Frank,
  • Susan Lei,
  • the Answer ALS Consortium,
  • Jennifer E. Van Eyk,
  • Steve Finkbeiner,
  • Jeffrey D. Rothstein,
  • Leslie M. Thompson,
  • Dhruv Sareen,
  • Clive N. Svendsen,
  • Ernest Fraenkel

DOI
https://doi.org/10.1038/s41467-024-47758-8
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 15

Abstract

Read online

Abstract Amyotrophic Lateral Sclerosis (ALS), like many other neurodegenerative diseases, is highly heritable, but with only a small fraction of cases explained by monogenic disease alleles. To better understand sporadic ALS, we report epigenomic profiles, as measured by ATAC-seq, of motor neuron cultures derived from a diverse group of 380 ALS patients and 80 healthy controls. We find that chromatin accessibility is heavily influenced by sex, the iPSC cell type of origin, ancestry, and the inherent variance arising from sequencing. Once these covariates are corrected for, we are able to identify ALS-specific signals in the data. Additionally, we find that the ATAC-seq data is able to predict ALS disease progression rates with similar accuracy to methods based on biomarkers and clinical status. These results suggest that iPSC-derived motor neurons recapitulate important disease-relevant epigenomic changes.